Carregant...
Global and Regional Burden of Isoniazid-Resistant Tuberculosis
BACKGROUND: Isoniazid has been the backbone of tuberculosis chemotherapy for 6 decades. Resistance to isoniazid threatens the efficacy of treatment of tuberculosis disease and infection. To inform policies around treatment of tuberculosis disease and infection in children, we sought to estimate both...
Guardat en:
| Publicat a: | Pediatrics |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Academy of Pediatrics
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485010/ https://ncbi.nlm.nih.gov/pubmed/26034243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2015-0172 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|